MetaADEDB 2.0 @ LMMD
Nicotine
(SNICXCGAKADSCV-JTQLQIEISA-N)
Structure
SMILES
CN1CCC[C@H]1c1cccnc1
Type(s)
Approved
ATC code(s)
N07BA01
Molecular Formula:
C10H14N2
Molecular Weight:
162.232
Log P:
1.7862
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
0
TPSA:
16.13
CAS Number(s):
54-11-5; 20033; 29790-52-1
Synonym(s)
1.
Nicotine
2.
Nicotine Bitartrate
3.
Nicotine Tartrate
External Link(s)
MeSHD009538
PubChem Compound89594
BindingDB50035403
82070
ChEBI17688
CHEMBLCHEMBL3
DrugBankDB00184
DrugCentral1920
IUPHAR/BPS Guide to PHARMACOLOGY2585
KEGGcpd:C00745
dr:D03365
Therapeutic Target DatabaseD05QIM
D0T8GD
ZINC391812
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Nicotine DependenceFAERS: 3816
Canada Vigilance: 18
Canada Vigilance
OFFSIDES
SIDER
US FAERS
2Drug ineffectiveFAERS: 2881
Canada Vigilance: 70
Canada Vigilance
OFFSIDES
US FAERS
3Intentional drug misuseFAERS: 2813OFFSIDES
US FAERS
4Application site erythemaFAERS: 2549
Canada Vigilance: 19
Canada Vigilance
OFFSIDES
US FAERS
5Application site pruritusFAERS: 2466
Canada Vigilance: 16
Canada Vigilance
OFFSIDES
US FAERS
6NauseaFAERS: 2221
Canada Vigilance: 95

View details

CTD
SIDER
Canada Vigilance
US FAERS
7Product quality issueFAERS: 1661
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
8DizzinessFAERS: 1312
Canada Vigilance: 90

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
9MalaiseFAERS: 1203
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
10Drug administration errorFAERS: 1105OFFSIDES
US FAERS
11Application site irritationFAERS: 897
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
12Product adhesion issueFAERS: 882
Canada Vigilance: 7
Canada Vigilance
US FAERS
13VomitingFAERS: 847
Canada Vigilance: 39

View details

CTD
SIDER
Canada Vigilance
US FAERS
14HeadacheFAERS: 830
Canada Vigilance: 64
8130921
8409878
16330293
CTD
SIDER
Canada Vigilance
US FAERS
15Application site painFAERS: 802
Canada Vigilance: 15
Canada Vigilance
OFFSIDES
US FAERS
16Application site rashFAERS: 756
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
17HypersensitivityFAERS: 756
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
18Application site reactionFAERS: 718
Canada Vigilance: 187
Canada Vigilance
OFFSIDES
SIDER
US FAERS
19OverdoseFAERS: 714
Canada Vigilance: 19
Canada Vigilance
OFFSIDES
US FAERS
20Wrong technique in product usage processFAERS: 684
Canada Vigilance: 5
Canada Vigilance
US FAERS
21Incorrect drug administration durationFAERS: 563OFFSIDES
US FAERS
22Application site swellingFAERS: 530
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
23Feeling abnormalFAERS: 499
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
24PruritusFAERS: 411
Canada Vigilance: 31
8130921CTD
SIDER
Canada Vigilance
US FAERS
25DysgeusiaFAERS: 380
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
26AnxietyFAERS: 374
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
27Application site urticariaFAERS: 369
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
28PalpitationsFAERS: 360
Canada Vigilance: 37
Canada Vigilance
SIDER
US FAERS
29Throat irritationFAERS: 349
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
30DependenceFAERS: 348
Canada Vigilance: 9
Canada Vigilance
OFFSIDES
SIDER
US FAERS
31Drug DependenceFAERS: 337
Canada Vigilance: 40
Canada Vigilance
US FAERS
32Expired product administeredFAERS: 320US FAERS
33TremorFAERS: 299
Canada Vigilance: 26

View details

CTD
SIDER
Canada Vigilance
US FAERS
34NervousnessFAERS: 291
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
35DyspepsiaFAERS: 290
Canada Vigilance: 15
Canada Vigilance
OFFSIDES
SIDER
US FAERS
36Pharmaceutical product complaintFAERS: 279OFFSIDES
US FAERS
37Drug dose omissionFAERS: 273US FAERS
38Abdominal discomfortFAERS: 255
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
39Chest PainFAERS: 254
Canada Vigilance: 58
9179092
9687945
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
40FatigueFAERS: 240
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
41Application site vesiclesFAERS: 236
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
42UrticariaFAERS: 227
Canada Vigilance: 26
Canada Vigilance
SIDER
US FAERS
43ErythemaFAERS: 212
Canada Vigilance: 21
8746358CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
44AstheniaFAERS: 208
Canada Vigilance: 16
Canada Vigilance
OFFSIDES
SIDER
US FAERS
45Incorrect dose administeredFAERS: 203US FAERS
46Oropharyngeal painFAERS: 182
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
47Feeling jitteryFAERS: 180
Canada Vigilance: 2
Canada Vigilance
US FAERS
48Drug abuserFAERS: 177OFFSIDES
US FAERS
49PainFAERS: 176
Canada Vigilance: 40

View details

CTD
SIDER
Canada Vigilance
US FAERS
50Inappropriate schedule of drug administrationFAERS: 175OFFSIDES
US FAERS
51StomatitisFAERS: 171
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
52Oral painFAERS: 159US FAERS
53Product complaintFAERS: 159
Canada Vigilance: 8
Canada Vigilance
US FAERS
54Application site papulesFAERS: 157OFFSIDES
US FAERS
55Burning sensationFAERS: 154
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
56Application site warmthFAERS: 138
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
57Myocardial InfarctionFAERS: 136
Canada Vigilance: 24

View details

CTD
Canada Vigilance
US FAERS
58Blood glucose increasedFAERS: 126
Canada Vigilance: 3
Canada Vigilance
US FAERS
59Chest discomfortFAERS: 125
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
60Application site burnFAERS: 123
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
US FAERS
61Adverse eventFAERS: 122
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
62SomnolenceFAERS: 119
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
63MyalgiaFAERS: 117
Canada Vigilance: 33
Canada Vigilance
SIDER
US FAERS
64Product dose omissionFAERS: 116
Canada Vigilance: 1
Canada Vigilance
US FAERS
65RetchingFAERS: 115US FAERS
66Accidental exposure to productFAERS: 112
Canada Vigilance: 4
Canada Vigilance
US FAERS
67FlatulenceFAERS: 111
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
68Euphoric moodFAERS: 110
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
69Product use issueFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Thermal burnFAERS: 95
Canada Vigilance: 3
Canada Vigilance
US FAERS
71Expired drug administeredFAERS: 90OFFSIDES
US FAERS
72Skin irritationFAERS: 89
Canada Vigilance: 3
Canada Vigilance
US FAERS
73Therapeutic response unexpectedFAERS: 89OFFSIDES
US FAERS
74Drug withdrawal syndromeFAERS: 84
Canada Vigilance: 2
Canada Vigilance
US FAERS
75ConstipationFAERS: 83
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
76Medication ErrorFAERS: 83
Canada Vigilance: 4
Canada Vigilance
US FAERS
77Drug exposure during pregnancyFAERS: 78OFFSIDES
US FAERS
78ToothacheFAERS: 78
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
79Nonspecific reactionFAERS: 77US FAERS
80RestlessnessFAERS: 77US FAERS
81No adverse eventFAERS: 76US FAERS
82Dental cariesFAERS: 75OFFSIDES
US FAERS
83AgitationFAERS: 71
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
84Poor quality sleepFAERS: 71US FAERS
85SyncopeFAERS: 71
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
86ArthralgiaFAERS: 70
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
87Intentional product use issueFAERS: 70
Canada Vigilance: 6
Canada Vigilance
US FAERS
88DiscomfortFAERS: 69SIDER
US FAERS
89EructationFAERS: 66
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
90Intentional product misuseFAERS: 62
Canada Vigilance: 2
Canada Vigilance
US FAERS
91Cerebrovascular accidentFAERS: 61
Canada Vigilance: 3
Canada Vigilance
US FAERS
92StressFAERS: 61
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
93AngerFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
94Application site drynessFAERS: 60OFFSIDES
US FAERS
95Depressed moodFAERS: 59
Canada Vigilance: 2
Canada Vigilance
US FAERS
96DisorientationFAERS: 58
Canada Vigilance: 13
Canada Vigilance
US FAERS
97Application site exfoliationFAERS: 56
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
98Accidental exposureFAERS: 55OFFSIDES
US FAERS
99CryingFAERS: 55US FAERS
100Weight decreasedFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
101Pharyngolaryngeal PainFAERS: 53OFFSIDES
SIDER
US FAERS
102Product selection errorFAERS: 53US FAERS
103Tobacco userFAERS: 53OFFSIDES
US FAERS
104Drug effect incompleteFAERS: 51US FAERS
105Incorrect route of drug administrationFAERS: 51OFFSIDES
US FAERS
106AsthmaFAERS: 50
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
107Back PainFAERS: 50
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
108Incorrect product administration durationFAERS: 48
Canada Vigilance: 15
Canada Vigilance
US FAERS
109Product taste abnormalFAERS: 48US FAERS
110TensionFAERS: 48SIDER
US FAERS
111AlopeciaFAERS: 47
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
112Cold sweatFAERS: 47
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
113PneumoniaFAERS: 47
Canada Vigilance: 3
Canada Vigilance
US FAERS
114Application site scarFAERS: 46
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
115Drug toxicityFAERS: 45OFFSIDES
US FAERS
116Inappropriate schedule of product administrationFAERS: 45
Canada Vigilance: 3
Canada Vigilance
US FAERS
117Lip swellingFAERS: 45US FAERS
118Angina PectorisFAERS: 44
Canada Vigilance: 7
Canada Vigilance
US FAERS
119Application site inflammationFAERS: 44US FAERS
120Application site scabFAERS: 43
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
121SwellingFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
122NasopharyngitisFAERS: 41
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
123Peripheral swellingFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Product use in unapproved indicationFAERS: 40US FAERS
125VertigoFAERS: 40
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
126DysphoniaFAERS: 39
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
127Abdominal PainFAERS: 38
Canada Vigilance: 15
9179092CTD
SIDER
Canada Vigilance
US FAERS
128Middle insomniaFAERS: 38US FAERS
129Musculoskeletal PainFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
130PallorFAERS: 38
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
131SneezingFAERS: 38SIDER
US FAERS
132AgeusiaFAERS: 37US FAERS
133Choking sensationFAERS: 37OFFSIDES
US FAERS
134ChokingFAERS: 36
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
135Wrong technique in drug usage processFAERS: 36OFFSIDES
US FAERS
136Application site discomfortFAERS: 35US FAERS
137GlossitisFAERS: 35US FAERS
138InfluenzaFAERS: 35SIDER
US FAERS
139Oropharyngeal blisteringFAERS: 35US FAERS
140Rash erythematousFAERS: 35
Canada Vigilance: 4
Canada Vigilance
US FAERS
141AnorexiaFAERS: 34US FAERS
142Tooth LossFAERS: 32OFFSIDES
US FAERS
143EpistaxisFAERS: 31
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
144Poor quality drug administeredFAERS: 31US FAERS
145ChillsFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
146Mental impairmentFAERS: 30
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
147Obsessive thoughtsFAERS: 30OFFSIDES
US FAERS
148Productive CoughFAERS: 30OFFSIDES
US FAERS
149Visual ImpairmentFAERS: 30
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
150Initial insomniaFAERS: 29US FAERS
151Skin reactionFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
152TachycardiaFAERS: 29
Canada Vigilance: 12
1259687
7925598
18567834
CTD
SIDER
Canada Vigilance
US FAERS
153ThirstFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
154Feeling ColdFAERS: 28
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
155Neck PainFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
156Oropharyngeal discomfortFAERS: 28OFFSIDES
US FAERS
157Accidental exposure to product by childFAERS: 27
Canada Vigilance: 3
Canada Vigilance
US FAERS
158BronchitisFAERS: 2727806211CTD
OFFSIDES
SIDER
US FAERS
159Application site erosionFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
160Memory impairmentFAERS: 26
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
161Mood swingsFAERS: 26
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
162Tongue blisteringFAERS: 26US FAERS
163DysarthriaFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
164Extra dose administeredFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
165Joint swellingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Application site hypersensitivityFAERS: 24US FAERS
167Circumstance or information capable of leading to medication errorFAERS: 24OFFSIDES
US FAERS
168Emotional disorderFAERS: 24OFFSIDES
US FAERS
169Nasal discomfortFAERS: 24OFFSIDES
SIDER
US FAERS
170LethargyFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Skin UlcerFAERS: 23US FAERS
172TinnitusFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
173AmnesiaFAERS: 22

View details

CTD
SIDER
US FAERS
174Application site dischargeFAERS: 22US FAERS
175Drug abuseFAERS: 22
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
176HypotensionFAERS: 22
Canada Vigilance: 2
7027322CTD
SIDER
Canada Vigilance
US FAERS
177Eye painFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
178ScabFAERS: 21
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
179ThrombosisFAERS: 21

View details

CTD
US FAERS
180DehydrationFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Dry skinFAERS: 20
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
182Aphthous StomatitisFAERS: 19OFFSIDES
SIDER
US FAERS
183Diabetes MellitusFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
184Drug prescribing errorFAERS: 19US FAERS
185HungerFAERS: 19US FAERS
186Night sweatsFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Blood cholesterol increasedFAERS: 18US FAERS
188Facial PainFAERS: 18US FAERS
189Increased upper airway secretionFAERS: 18US FAERS
190Product storage errorFAERS: 18US FAERS
191Tooth ExtractionFAERS: 18US FAERS
192WheezingFAERS: 18US FAERS
193AcneFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
194Application site perspirationFAERS: 17OFFSIDES
US FAERS
195Atrial FibrillationFAERS: 173945010
7703770
12713677
CTD
SIDER
US FAERS
196HyperchlorhydriaFAERS: 17US FAERS
197HypersomniaFAERS: 17US FAERS
198Oral mucosal eruptionFAERS: 17US FAERS
199Tongue discomfortFAERS: 17US FAERS
200Visual disturbanceFAERS: 17US FAERS
201Cardiac ArrestFAERS: 16US FAERS
202Cardiac FlutterFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
203Eye irritationFAERS: 16SIDER
US FAERS
204Product label issueFAERS: 16US FAERS
205Product packaging issueFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
206Product physical issueFAERS: 16US FAERS
207AngioedemaFAERS: 15
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
208Drug screen positiveFAERS: 15US FAERS
209Incorrect route of product administrationFAERS: 15US FAERS
210Musculoskeletal stiffnessFAERS: 15
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
211Oral mucosal exfoliationFAERS: 15US FAERS
212Toxicity to various agentsFAERS: 15US FAERS
213Wrong drug administeredFAERS: 15US FAERS
214Application site ulcerFAERS: 14US FAERS
215Bone painFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
216Device FailureFAERS: 14US FAERS
217FlushingFAERS: 14
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
218FormicationFAERS: 14OFFSIDES
US FAERS
219Gastric ulcerFAERS: 14OFFSIDES
SIDER
US FAERS
220Gingival blisterFAERS: 14US FAERS
221Head discomfortFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
222Muscle tightnessFAERS: 14OFFSIDES
US FAERS
223Suicide attemptFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
224AnosmiaFAERS: 13OFFSIDES
US FAERS
225Drug effective for unapproved indicationFAERS: 13US FAERS
226Gastrointestinal PainFAERS: 13SIDER
US FAERS
227LacerationFAERS: 13US FAERS
228MydriasisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Product substitution issueFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
230ChromaturiaFAERS: 12US FAERS
231Gingival erythemaFAERS: 12OFFSIDES
US FAERS
232InfectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
233Limb discomfortFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
234PancreatitisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
235PoisoningFAERS: 12
Canada Vigilance: 3
2371153
5644266
CTD
Canada Vigilance
US FAERS
236UlcerFAERS: 12US FAERS
237Accidental overdoseFAERS: 11
Canada Vigilance: 5
Canada Vigilance
US FAERS
238BedriddenFAERS: 11US FAERS
239BlindnessFAERS: 11US FAERS
240Blood potassium increasedFAERS: 11US FAERS
241CheilitisFAERS: 11US FAERS
242Chemical injuryFAERS: 11US FAERS
243Drug ineffective for unapproved indicationFAERS: 11US FAERS
244EczemaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
245Emotional distressFAERS: 11US FAERS
246GingivitisFAERS: 11
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
247Respiratory distressFAERS: 11US FAERS
248Tobacco withdrawal symptomsFAERS: 11OFFSIDES
SIDER
US FAERS
249Tooth ErosionFAERS: 11OFFSIDES
US FAERS
250AphasiaFAERS: 10SIDER
US FAERS
251AphoniaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Intentional misuseFAERS: 10OFFSIDES
US FAERS
253Musculoskeletal discomfortFAERS: 10SIDER
US FAERS
254Pain of skinFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
255Product formulation issueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
256StillbirthFAERS: 10US FAERS
257Urinary tract infectionFAERS: 10US FAERS
258AbasiaFAERS: 9US FAERS
259Anaphylactic shockFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
260Blood pressure fluctuationFAERS: 9SIDER
US FAERS
261Concomitant disease aggravatedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
262DementiaFAERS: 9US FAERS
263DermatitisFAERS: 9
Canada Vigilance: 3
9565740CTD
SIDER
Canada Vigilance
US FAERS
264Drug administered to patient of inappropriate ageFAERS: 9US FAERS
265Food cravingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
266HyperventilationFAERS: 9
Canada Vigilance: 3
3976905CTD
Canada Vigilance
US FAERS
267Hypoaesthesia facialFAERS: 9US FAERS
268Limb injuryFAERS: 9US FAERS
269Mastication disorderFAERS: 9US FAERS
270PresyncopeFAERS: 9US FAERS
271PsoriasisFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
272ScreamingFAERS: 9US FAERS
273nervous system disorderFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
274Application site excoriationFAERS: 8OFFSIDES
US FAERS
275Application site infectionFAERS: 8US FAERS
276ArthritisFAERS: 88746358CTD
OFFSIDES
SIDER
US FAERS
277Cerebral InfarctionFAERS: 8US FAERS
278Drug dispensing errorFAERS: 8US FAERS
279EpilepsyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
280Erectile dysfunctionFAERS: 8
Canada Vigilance: 1
17971108CTD
Canada Vigilance
US FAERS
281HyperphagiaFAERS: 8US FAERS
282LymphadenopathyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
283Product container issueFAERS: 8US FAERS
284Product package associated injuryFAERS: 8US FAERS
285Renal painFAERS: 8US FAERS
286Shoulder PainFAERS: 8OFFSIDES
US FAERS
287SinusitisFAERS: 8SIDER
US FAERS
288Apparent deathFAERS: 7US FAERS
289Application site acneFAERS: 7US FAERS
290Application site lacerationFAERS: 7US FAERS
291Bipolar DisorderFAERS: 719628140CTD
US FAERS
292Caustic injuryFAERS: 7OFFSIDES
US FAERS
293Chemical burn of skinFAERS: 7OFFSIDES
US FAERS
294Completed SuicideFAERS: 7
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
295DiplopiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
296Drug effect variableFAERS: 7US FAERS
297Ear discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Epigastric discomfortFAERS: 7US FAERS
299Frustration tolerance decreasedFAERS: 7US FAERS
300HypogeusiaFAERS: 7US FAERS
301HypothyroidismFAERS: 7US FAERS
302Idiosyncratic drug reactionFAERS: 7US FAERS
303InflammationFAERS: 7
Canada Vigilance: 1
18068289
19586999
20943775
CTD
Canada Vigilance
US FAERS
304Intercepted medication errorFAERS: 7US FAERS
305Mouth swellingFAERS: 7US FAERS
306Nerve injuryFAERS: 7US FAERS
307Oral pruritusFAERS: 7US FAERS
308ParanoiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Performance status decreasedFAERS: 7US FAERS
310Skin tightnessFAERS: 7US FAERS
311Throat cancerFAERS: 7OFFSIDES
US FAERS
312Unevaluable eventFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
313Accidental drug intake by childFAERS: 6US FAERS
314Application site indurationFAERS: 6US FAERS
315Application site noduleFAERS: 6US FAERS
316ArthropathyFAERS: 6OFFSIDES
US FAERS
317AsphyxiaFAERS: 6US FAERS
318Contraindicated product administeredFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
319DeafnessFAERS: 6US FAERS
320Electrocardiogram abnormalFAERS: 6
Canada Vigilance: 4
Canada Vigilance
US FAERS
321Enamel anomalyFAERS: 6US FAERS
322Gingival RecessionFAERS: 6US FAERS
323ImpatienceFAERS: 6US FAERS
324Lip and/or oral cavity cancerFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
325Loose toothFAERS: 6OFFSIDES
US FAERS
326Multiple SclerosisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
327NarcolepsyFAERS: 6US FAERS
328Oral mucosal erythemaFAERS: 6US FAERS
329Panic DisorderFAERS: 63777262
26688438
CTD
US FAERS
330Poor quality product administeredFAERS: 6US FAERS
331Product packaging quantity issueFAERS: 6US FAERS
332Respiratory arrestFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
333Therapy cessationFAERS: 6US FAERS
334treatment failureFAERS: 6US FAERS
335Activities of daily living impairedFAERS: 5US FAERS
336Anaphylactoid ReactionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
337ApathyFAERS: 5OFFSIDES
SIDER
US FAERS
338AphagiaFAERS: 5OFFSIDES
US FAERS
339Application site coldnessFAERS: 5US FAERS
340Blood glucose decreasedFAERS: 5OFFSIDES
US FAERS
341Blood potassium decreasedFAERS: 5US FAERS
342BruxismFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
343Dental discomfortFAERS: 5US FAERS
344Depressed Level of ConsciousnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
345DisabilityFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
346DissociationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
347DroolingFAERS: 5US FAERS
348Drug administered at inappropriate siteFAERS: 5US FAERS
349Elevated moodFAERS: 5US FAERS
350ExcoriationFAERS: 5US FAERS
351FractureFAERS: 5US FAERS
352GastritisFAERS: 5US FAERS
353General physical health deteriorationFAERS: 5OFFSIDES
US FAERS
354Gingival discomfortFAERS: 5US FAERS
355HyperkeratosisFAERS: 5US FAERS
356Impaired driving abilityFAERS: 5US FAERS
357Joint stiffnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
358Lip exfoliationFAERS: 5US FAERS
359Maternal exposure during pregnancyFAERS: 5US FAERS
360MetrorrhagiaFAERS: 5US FAERS
361OsteoporosisFAERS: 5US FAERS
362PleurisyFAERS: 5US FAERS
363Prescribed overdoseFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
364Prescription drug used without a prescriptionFAERS: 5US FAERS
365Respiratory FailureFAERS: 5SIDER
US FAERS
366Respiratory tract congestionFAERS: 5US FAERS
367Rubber sensitivityFAERS: 5US FAERS
368SepsisFAERS: 5US FAERS
369Sexual DysfunctionFAERS: 5US FAERS
370Skin hypertrophyFAERS: 5OFFSIDES
US FAERS
371Skin lacerationFAERS: 5OFFSIDES
US FAERS
372Skin lesionFAERS: 5US FAERS
373Sleep TalkingFAERS: 5OFFSIDES
US FAERS
374SluggishnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
375Tongue eruptionFAERS: 5US FAERS
376Tooth InfectionFAERS: 5US FAERS
377VIIth nerve paralysisFAERS: 5US FAERS
378Adnexa uteri massFAERS: 4US FAERS
379AppendicitisFAERS: 4OFFSIDES
US FAERS
380AsthenopiaFAERS: 4US FAERS
381Auricular swellingFAERS: 4OFFSIDES
US FAERS
382Back disorderFAERS: 4US FAERS
383Blood glucose fluctuationFAERS: 4US FAERS
384Blood triglycerides increasedFAERS: 4US FAERS
385Blood urine presentFAERS: 4US FAERS
386CellulitisFAERS: 4US FAERS
387CyanosisFAERS: 41259687CTD
US FAERS
388Device malfunctionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
389DiverticulitisFAERS: 4OFFSIDES
US FAERS
390Drug screen false positiveFAERS: 4US FAERS
391DysuriaFAERS: 4US FAERS
392Electrolyte imbalanceFAERS: 4US FAERS
393Eye BurnsFAERS: 4US FAERS
394Foaming at mouthFAERS: 4US FAERS
395HerniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
396Intestinal ObstructionFAERS: 4US FAERS
397Joint injuryFAERS: 4US FAERS
398LaryngitisFAERS: 4US FAERS
399LymphomaFAERS: 4US FAERS
400Musculoskeletal chest painFAERS: 4US FAERS
401NephrolithiasisFAERS: 4US FAERS
402OophoritisFAERS: 4US FAERS
403Oral candidiasisFAERS: 4US FAERS
404ParesisFAERS: 41736170CTD
US FAERS
405Pharyngolaryngeal discomfortFAERS: 4US FAERS
406Physical product label issueFAERS: 4US FAERS
407Pleuritic painFAERS: 4US FAERS
408Poor peripheral circulationFAERS: 4US FAERS
409Pre-EclampsiaFAERS: 4OFFSIDES
US FAERS
410Precancerous cells presentFAERS: 4US FAERS
411Prescribed underdoseFAERS: 4US FAERS
412Product administered at inappropriate siteFAERS: 4US FAERS
413Product label confusionFAERS: 4US FAERS
414Product physical consistency issueFAERS: 4US FAERS
415Product tamperingFAERS: 4US FAERS
416ShockFAERS: 4SIDER
US FAERS
417Sinus headacheFAERS: 4US FAERS
418SmokerFAERS: 4US FAERS
419SunburnFAERS: 4US FAERS
420Tongue bitingFAERS: 4US FAERS
421TrismusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
422Urinary IncontinenceFAERS: 4US FAERS
423Adhesive tape useFAERS: 3US FAERS
424AneurysmFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
425BlepharospasmFAERS: 3US FAERS
426Blood blisterFAERS: 3US FAERS
427Blood pH decreasedFAERS: 3US FAERS
428Bowel movement irregularityFAERS: 3US FAERS
429BradycardiaFAERS: 3

View details

CTD
US FAERS
430CataplexyFAERS: 3OFFSIDES
US FAERS
431Cerebellar infarctionFAERS: 3OFFSIDES
US FAERS
432Complications of maternal exposure to therapeutic drugsFAERS: 3OFFSIDES
US FAERS
433Conversion disorderFAERS: 3US FAERS
434DeliriumFAERS: 3
Canada Vigilance: 1
9737096
12325491
CTD
Canada Vigilance
US FAERS
435Drug label confusionFAERS: 3US FAERS
436Emergency CareFAERS: 3US FAERS
437Emergency care examinationFAERS: 3US FAERS
438Endodontic procedureFAERS: 3US FAERS
439Feeling of body temperature changeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
440FrustrationFAERS: 3OFFSIDES
US FAERS
441Gastrointestinal sounds abnormalFAERS: 3US FAERS
442Genital rashFAERS: 3US FAERS
443HemiparesisFAERS: 3OFFSIDES
US FAERS
444HemiplegiaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
445HidradenitisFAERS: 3US FAERS
446Hypertensive crisisFAERS: 3US FAERS
447Hypertrophy of tongue papillaeFAERS: 3US FAERS
448HypokinesiaFAERS: 3
Canada Vigilance: 4
12234654CTD
Canada Vigilance
US FAERS
449HypoventilationFAERS: 3US FAERS
450Inappropriate affectFAERS: 3US FAERS
451Incorrect product storageFAERS: 3US FAERS
452InfarctionFAERS: 3US FAERS
453Intentional self-injuryFAERS: 3US FAERS
454Intracranial AneurysmFAERS: 3US FAERS
455Kounis SyndromeFAERS: 3US FAERS
456LeukoplakiaFAERS: 3US FAERS
457Low birth weight babyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
458Low density lipoprotein increasedFAERS: 3US FAERS
459Lower respiratory tract infectionFAERS: 3US FAERS
460MonoplegiaFAERS: 3OFFSIDES
US FAERS
461Motion SicknessFAERS: 317990061CTD
US FAERS
462Muscle hypertrophyFAERS: 3US FAERS
463Ocular icterusFAERS: 3US FAERS
464OnychoclasisFAERS: 3US FAERS
465Oropharyngeal plaqueFAERS: 3US FAERS
466Pre-existing condition improvedFAERS: 3US FAERS
467PregnancyFAERS: 3US FAERS
468Product administration interruptedFAERS: 3US FAERS
469Product counterfeitFAERS: 3US FAERS
470Product dispensing errorFAERS: 3US FAERS
471Product residue presentFAERS: 3US FAERS
472Product shape issueFAERS: 3US FAERS
473Product size issueFAERS: 3US FAERS
474Product solubility abnormalFAERS: 3US FAERS
475Product use complaintFAERS: 3US FAERS
476Purulent dischargeFAERS: 3US FAERS
477Reaction to drug excipientsFAERS: 3US FAERS
478Restless Legs SyndromeFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
479RhinalgiaFAERS: 3US FAERS
480Saliva alteredFAERS: 3US FAERS
481Secretion dischargeFAERS: 3US FAERS
482Sensation of blood flowFAERS: 3US FAERS
483Skin ErosionFAERS: 3US FAERS
484Skin WrinklingFAERS: 3US FAERS
485StrabismusFAERS: 3US FAERS
486Therapeutic product effect incompleteFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
487Therapy non-responderFAERS: 3OFFSIDES
US FAERS
488Tongue pruritusFAERS: 3US FAERS
489Transaminases increasedFAERS: 3OFFSIDES
US FAERS
490Urinary RetentionFAERS: 3US FAERS
491Violence-related symptomFAERS: 3US FAERS
492White blood cell count decreasedFAERS: 3US FAERS
493furuncleFAERS: 3US FAERS
494Abdominal tendernessFAERS: 2US FAERS
495Acute sinusitisFAERS: 2US FAERS
496Adnexa uteri painFAERS: 2US FAERS
497Alcohol IntoleranceFAERS: 2US FAERS
498Alcohol interactionFAERS: 2US FAERS
499Alcohol withdrawal syndromeFAERS: 2US FAERS
500Allergic reaction to excipientFAERS: 2US FAERS
501Antibody test abnormalFAERS: 2US FAERS
502Application site eczemaFAERS: 2US FAERS
503Application site pustulesFAERS: 2US FAERS
504Application site woundFAERS: 2US FAERS
505Arthropod biteFAERS: 2US FAERS
506AsbestosisFAERS: 2US FAERS
507Blood carbon monoxide increasedFAERS: 2US FAERS
508Blood count abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
509Blood iron increasedFAERS: 2US FAERS
510Blood phosphorus increasedFAERS: 2OFFSIDES
US FAERS
511Blood pressure immeasurableFAERS: 2OFFSIDES
US FAERS
512BoredomFAERS: 2US FAERS
513Breath alcohol test positiveFAERS: 2US FAERS
514BronchopneumoniaFAERS: 2US FAERS
515BronchospasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
516Buccal mucosal rougheningFAERS: 2US FAERS
517Carcinoembryonic antigen increasedFAERS: 2US FAERS
518CataractFAERS: 2US FAERS
519Cerebral atrophyFAERS: 2US FAERS
520ChloasmaFAERS: 2US FAERS
521ClumsinessFAERS: 2US FAERS
522Coronary angioplastyFAERS: 2US FAERS
523Decompression SicknessFAERS: 2US FAERS
524Device use errorFAERS: 2US FAERS
525Diastolic dysfunctionFAERS: 2US FAERS
526DiplegiaFAERS: 2US FAERS
527Disease ProgressionFAERS: 2OFFSIDES
US FAERS
528Drug effect delayedFAERS: 2US FAERS
529Drug exposure via breast milkFAERS: 2US FAERS
530Duodenal UlcerFAERS: 2US FAERS
531EnuresisFAERS: 2OFFSIDES
US FAERS
532Erythema MultiformeFAERS: 2OFFSIDES
US FAERS
533ExcitabilityFAERS: 2US FAERS
534Exposure to toxic agentFAERS: 2US FAERS
535Exposure via eye contactFAERS: 2US FAERS
536Eye InfectionFAERS: 2US FAERS
537Feeding disorder neonatalFAERS: 2US FAERS
538FibromyalgiaFAERS: 2OFFSIDES
US FAERS
539Food PoisoningFAERS: 2US FAERS
540Foreign body traumaFAERS: 2US FAERS
541Hip surgeryFAERS: 2OFFSIDES
US FAERS
542HyperacusisFAERS: 2US FAERS
543HypermetabolismFAERS: 2US FAERS
544HypophagiaFAERS: 2US FAERS
545HypoxiaFAERS: 214980338CTD
US FAERS
546HysterectomyFAERS: 2US FAERS
547Impaired work abilityFAERS: 2US FAERS
548IncoherentFAERS: 2US FAERS
549IncontinenceFAERS: 2US FAERS
550Increased tendency to bruiseFAERS: 2US FAERS
551InfertilityFAERS: 220363831CTD
US FAERS
552Intercepted drug administration errorFAERS: 2US FAERS
553Intestinal resectionFAERS: 2US FAERS
554Intranasal numbnessFAERS: 2US FAERS
555Intrauterine infectionFAERS: 2OFFSIDES
US FAERS
556Irritable Bowel SyndromeFAERS: 2US FAERS
557LabyrinthitisFAERS: 2US FAERS
558Lack of application site rotationFAERS: 2US FAERS
559Larynx irritationFAERS: 2US FAERS
560MastectomyFAERS: 2US FAERS
561Mechanical ventilationFAERS: 2OFFSIDES
US FAERS
562Medication residue presentFAERS: 2US FAERS
563MenorrhagiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
564Mental status changesFAERS: 2US FAERS
565Muscle strainFAERS: 2US FAERS
566Neonatal disorderFAERS: 2US FAERS
567NeuralgiaFAERS: 2US FAERS
568Noninfective gingivitisFAERS: 2US FAERS
569ObesityFAERS: 220363831
23623838
CTD
US FAERS
570OligohydramniosFAERS: 2US FAERS
571Open woundFAERS: 2OFFSIDES
US FAERS
572Oral infectionFAERS: 2OFFSIDES
US FAERS
573Oropharyngeal candidiasisFAERS: 2US FAERS
574Oropharyngeal swellingFAERS: 2OFFSIDES
US FAERS
575Oropharyngitis fungalFAERS: 2US FAERS
576OsteomyelitisFAERS: 2OFFSIDES
US FAERS
577OsteopeniaFAERS: 2US FAERS
578Pelvic PainFAERS: 2US FAERS
579Peripheral arterial occlusive diseaseFAERS: 2US FAERS
580Personality ChangeFAERS: 2US FAERS
581PharyngitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
582PiloerectionFAERS: 2US FAERS
583PneumonectomyFAERS: 2US FAERS
584PneumothoraxFAERS: 2US FAERS
585Post procedural complicationFAERS: 2US FAERS
586Premenstrual syndromeFAERS: 2US FAERS
587Pressure of speechFAERS: 2US FAERS
588Product coating issueFAERS: 2US FAERS
589Product expiration date issueFAERS: 2US FAERS
590Product prescribing errorFAERS: 2US FAERS
591Product supply issueFAERS: 2US FAERS
592Psychiatric symptomFAERS: 2US FAERS
593Pulmonary EmbolismFAERS: 2US FAERS
594Pulmonary congestionFAERS: 2US FAERS
595QuadriplegiaFAERS: 2OFFSIDES
US FAERS
596RegurgitationFAERS: 2US FAERS
597Respiratory fume inhalation disorderFAERS: 2OFFSIDES
US FAERS
598Respiratory tract irritationFAERS: 2US FAERS
599Rotator cuff syndromeFAERS: 2US FAERS
600Sinus TachycardiaFAERS: 2US FAERS
601Soft Tissue InfectionFAERS: 2US FAERS
602SomnambulismFAERS: 2US FAERS
603Sperm concentration zeroFAERS: 2US FAERS
604StaringFAERS: 2US FAERS
605Suspected counterfeit productFAERS: 2US FAERS
606TachyphreniaFAERS: 2US FAERS
607Teeth brittleFAERS: 2US FAERS
608Terminal stateFAERS: 2US FAERS
609Therapeutic product ineffectiveFAERS: 2US FAERS
610Therapy changeFAERS: 2US FAERS
611Tooth repairFAERS: 2US FAERS
612Unresponsive to stimuliFAERS: 2US FAERS
613Upper respiratory tract irritationFAERS: 2US FAERS
614Vein painFAERS: 2US FAERS
615Waist circumference increasedFAERS: 2OFFSIDES
US FAERS
616Walking aid userFAERS: 2US FAERS
617Wrong technique in device usage processFAERS: 2US FAERS
618jaundiceFAERS: 2US FAERS
619ovarian neoplasmFAERS: 2US FAERS
620skin abrasionFAERS: 2US FAERS
621Abdominal InfectionFAERS: 1US FAERS
622Abdominal rigidityFAERS: 1US FAERS
623Abnormal sleep-related eventFAERS: 1US FAERS
624AbscessFAERS: 1US FAERS
625Acquired Immunodeficiency SyndromeFAERS: 1US FAERS
626Acute Coronary SyndromeFAERS: 1US FAERS
627Acute kidney injuryFAERS: 121511693CTD
US FAERS
628Acute tonsillitisFAERS: 1US FAERS
629AgoraphobiaFAERS: 1US FAERS
630AgraphiaFAERS: 1OFFSIDES
US FAERS
631Airway burnsFAERS: 1US FAERS
632Alanine Aminotransferase IncreasedFAERS: 1US FAERS
633Alcohol problemFAERS: 1US FAERS
634Alcohol test false positiveFAERS: 1US FAERS
635Allergy to chemicalsFAERS: 1US FAERS
636Altered visual depth perceptionFAERS: 1US FAERS
637Anal discomfortFAERS: 1US FAERS
638AngioplastyFAERS: 1US FAERS
639AnhedoniaFAERS: 126688438CTD
US FAERS
640Anorectal discomfortFAERS: 1US FAERS
641AnorgasmiaFAERS: 1US FAERS
642Anoxic EncephalopathyFAERS: 1US FAERS
643Application site injuryFAERS: 1US FAERS
644Application site massFAERS: 1US FAERS
645Application site pigmentation changesFAERS: 1US FAERS
646Arterial stenosis limbFAERS: 1US FAERS
647ArteriosclerosisFAERS: 1812508CTD
OFFSIDES
US FAERS
648Arteriovenous fistula site complicationFAERS: 1US FAERS
649Arthropod stingFAERS: 1US FAERS
650Artificial crown procedureFAERS: 1US FAERS
651Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
652AtaxiaFAERS: 119281835
23219611
CTD
US FAERS
653Atrioventricular BlockFAERS: 11259687CTD
US FAERS
654Basal cell carcinomaFAERS: 1US FAERS
655Bladder discomfortFAERS: 1US FAERS
656Bladder painFAERS: 1SIDER
US FAERS
657Blood alkaline phosphatase increasedFAERS: 1US FAERS
658Blood arsenic increasedFAERS: 1US FAERS
659Blood creatinine increasedFAERS: 1US FAERS
660Blood electrolytes decreasedFAERS: 1US FAERS
661Blood glucose abnormalFAERS: 1US FAERS
662Blood immunoglobulin E increasedFAERS: 1US FAERS
663Blood ketone bodyFAERS: 1US FAERS
664Blood lactate dehydrogenase increasedFAERS: 1US FAERS
665Blood potassium abnormalFAERS: 1US FAERS
666Blood sodium abnormalFAERS: 1US FAERS
667Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
668Body fat disorderFAERS: 1US FAERS
669Body temperature fluctuationFAERS: 1US FAERS
670Bone contusionFAERS: 1US FAERS
671BradyphreniaFAERS: 1US FAERS
672Brain DeathFAERS: 1US FAERS
673Brain HypoxiaFAERS: 1OFFSIDES
US FAERS
674Breakthrough PainFAERS: 1US FAERS
675Breast FeedingFAERS: 1US FAERS
676Breech PresentationFAERS: 1US FAERS
677Bronchial HyperreactivityFAERS: 1US FAERS
678Brown-Sequard SyndromeFAERS: 1US FAERS
679Burning Mouth SyndromeFAERS: 1US FAERS
680Cardiac discomfortFAERS: 1US FAERS
681CardiomegalyFAERS: 1US FAERS
682Carotid artery occlusionFAERS: 1US FAERS
683Catheter placementFAERS: 1US FAERS
684Central nervous system lesionFAERS: 1US FAERS
685Cerebellar artery thrombosisFAERS: 1OFFSIDES
US FAERS
686Cerebellar strokeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
687Cerebral artery occlusionFAERS: 1US FAERS
688Cerebral vasoconstrictionFAERS: 1US FAERS
689Cervix carcinomaFAERS: 1US FAERS
690Chemical burn of gastrointestinal tractFAERS: 1US FAERS
691CholecystitisFAERS: 1US FAERS
692CholelithiasisFAERS: 1US FAERS
693Circumstance or information capable of leading to device use errorFAERS: 1US FAERS
694Cleft PalateFAERS: 1US FAERS
695Cluster HeadacheFAERS: 1US FAERS
696Coating in mouthFAERS: 1US FAERS
697Complement factor C4 increasedFAERS: 1US FAERS
698Concomitant disease progressionFAERS: 1US FAERS
699Consciousness fluctuatingFAERS: 1US FAERS
700Contraindicated drug administeredFAERS: 1US FAERS
701CoprolaliaFAERS: 1US FAERS
702Coronary Artery DiseaseFAERS: 111166759CTD
US FAERS
703CystitisFAERS: 1SIDER
US FAERS
704CystFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
705Dark circles under eyesFAERS: 1US FAERS
706Decreased immune responsivenessFAERS: 1US FAERS
707Deja VuFAERS: 1US FAERS
708Device adhesion issueFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
709Device breakageFAERS: 1US FAERS
710Device damageFAERS: 1US FAERS
711Device ineffectiveFAERS: 1OFFSIDES
US FAERS
712Device leakageFAERS: 1US FAERS
713Device occlusionFAERS: 1US FAERS
714Device toxicityFAERS: 1US FAERS
715Diabetes mellitus inadequate controlFAERS: 1US FAERS
716Discontinued product administeredFAERS: 1US FAERS
717Disease recurrenceFAERS: 1US FAERS
718Disseminated Intravascular CoagulationFAERS: 1US FAERS
719Dreamy stateFAERS: 1US FAERS
720Drug ToleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
721Drug addictFAERS: 1OFFSIDES
US FAERS
722Drug delivery system malfunctionFAERS: 1US FAERS
723Drug exposure before pregnancyFAERS: 1US FAERS
724Drug level increasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
725DysgraphiaFAERS: 1US FAERS
726DysphemiaFAERS: 1US FAERS
727DystoniaFAERS: 119404753CTD
US FAERS
728EclampsiaFAERS: 1US FAERS
729Ectopic PregnancyFAERS: 1US FAERS
730EncephalitisFAERS: 1US FAERS
731EndometriosisFAERS: 1US FAERS
732Enlarged uvulaFAERS: 1US FAERS
733EnteritisFAERS: 1US FAERS
734Epinephrine increasedFAERS: 1US FAERS
735EpiscleritisFAERS: 1US FAERS
736Erection increasedFAERS: 1US FAERS
737ErysipelasFAERS: 1US FAERS
738Excessive eye blinkingFAERS: 1US FAERS
739ExophthalmosFAERS: 1US FAERS
740Exposure during breast feedingFAERS: 1US FAERS
741Exposure to unspecified agentFAERS: 1US FAERS
742Exposure via skin contactFAERS: 1US FAERS
743Eyelid margin crustingFAERS: 1US FAERS
744Eyelids pruritusFAERS: 1US FAERS
745Facial NeuralgiaFAERS: 1US FAERS
746Failure of implantFAERS: 1US FAERS
747Food AllergyFAERS: 1US FAERS
748Foreign body in respiratory tractFAERS: 1US FAERS
749Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
750Gastric infectionFAERS: 1US FAERS
751Gastric mucosa erythemaFAERS: 1US FAERS
752GastroenteritisFAERS: 1OFFSIDES
US FAERS
753Gastrointestinal carcinomaFAERS: 1US FAERS
754Gastrointestinal infectionFAERS: 1US FAERS
755Gastrointestinal ulcerFAERS: 1US FAERS
756General physical condition abnormalFAERS: 1US FAERS
757Gestational DiabetesFAERS: 1US FAERS
758GlaucomaFAERS: 1US FAERS
759GoutFAERS: 1US FAERS
760Hallucinations, mixedFAERS: 1US FAERS
761Hepatitis CFAERS: 1US FAERS
762HepatitisFAERS: 1US FAERS
763HepatomegalyFAERS: 1US FAERS
764HippusFAERS: 1US FAERS
765HordeolumFAERS: 1US FAERS
766HostilityFAERS: 1US FAERS
767Human papilloma virus test positiveFAERS: 1US FAERS
768Hypertensive EncephalopathyFAERS: 1US FAERS
769HyperthyroidismFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
770HypertrophyFAERS: 120685820CTD
US FAERS
771HypervigilanceFAERS: 1US FAERS
772HypomaniaFAERS: 1US FAERS
773HypotrichosisFAERS: 1US FAERS
774ImmobileFAERS: 1US FAERS
775Inability to afford medicationFAERS: 1US FAERS
776Inadequate aseptic technique in use of productFAERS: 1US FAERS
777Increased viscosity of bronchial secretionFAERS: 1US FAERS
778Inhalation TherapyFAERS: 1US FAERS
779Injury asphyxiationFAERS: 1US FAERS
780Intercepted drug prescribing errorFAERS: 1US FAERS
781Japan coma scale abnormalFAERS: 1US FAERS
782Joint warmthFAERS: 1US FAERS
783Labile blood pressureFAERS: 1US FAERS
784Lack of administration site rotationFAERS: 1US FAERS
785LaryngospasmFAERS: 1US FAERS
786Leukocytoclastic vasculitisFAERS: 1US FAERS
787LeukocytosisFAERS: 1US FAERS
788Ligament ruptureFAERS: 1US FAERS
789Limb crushing injuryFAERS: 1US FAERS
790Limb operationFAERS: 1US FAERS
791Lip InfectionFAERS: 1US FAERS
792Lip sloughingFAERS: 1US FAERS
793Live BirthFAERS: 1US FAERS
794Livedo ReticularisFAERS: 1US FAERS
795Loss of personal independence in daily activitiesFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
796LymphadenitisFAERS: 1US FAERS
797LymphocytosisFAERS: 1OFFSIDES
US FAERS
798MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
799Macular degenerationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
800Macular fibrosisFAERS: 1US FAERS
801MalabsorptionFAERS: 1US FAERS
802Maternal exposure timing unspecifiedFAERS: 1US FAERS
803Medical device complicationFAERS: 1US FAERS
804Medication residueFAERS: 1US FAERS
805MeningitisFAERS: 1US FAERS
806MenopauseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
807MoaningFAERS: 1OFFSIDES
US FAERS
808Mouth plaqueFAERS: 1US FAERS
809Multiple MyelomaFAERS: 1US FAERS
810Multiple allergiesFAERS: 1US FAERS
811Multiple drug overdoseFAERS: 1OFFSIDES
US FAERS
812Muscle FatigueFAERS: 1OFFSIDES
US FAERS
813Myasthenia GravisFAERS: 1OFFSIDES
US FAERS
814MyoclonusFAERS: 11736170CTD
US FAERS
815MyopiaFAERS: 1US FAERS
816MyotoniaFAERS: 1US FAERS
817NecrosisFAERS: 1

View details

CTD
US FAERS
818Negative thoughtsFAERS: 1US FAERS
819Nerve root injuryFAERS: 1US FAERS
820NeuromaFAERS: 1US FAERS
821Nicotine poisoningFAERS: 1SIDER
US FAERS
822Nipple painFAERS: 1US FAERS
823No adverse drug reactionFAERS: 1US FAERS
824Non-cardiac chest painFAERS: 1US FAERS
825OnychomycosisFAERS: 1US FAERS
826OphthalmoplegiaFAERS: 1US FAERS
827Optic NeuritisFAERS: 1OFFSIDES
US FAERS
828Oropharyngeal spasmFAERS: 1US FAERS
829Oxygen supplementationFAERS: 1US FAERS
830PO2 increasedFAERS: 1US FAERS
831Palmar erythemaFAERS: 1US FAERS
832Pancreatic carcinomaFAERS: 1US FAERS
833PapuleFAERS: 1US FAERS
834Paradoxical drug reactionFAERS: 1US FAERS
835Paranasal sinus discomfortFAERS: 1US FAERS
836Patient dissatisfaction with treatmentFAERS: 1US FAERS
837Pelvic Inflammatory DiseaseFAERS: 1US FAERS
838Penile blisterFAERS: 1US FAERS
839Penile erythemaFAERS: 1US FAERS
840Peptic UlcerFAERS: 1US FAERS
841Pericardial effusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
842PeriodontitisFAERS: 1US FAERS
843Periorbital contusionFAERS: 1US FAERS
844Peripheral nerve lesionFAERS: 1US FAERS
845Peripheral nerve palsyFAERS: 1US FAERS
846Peritoneal fluid analysis abnormalFAERS: 1US FAERS
847PeritonitisFAERS: 1OFFSIDES
US FAERS
848PetechiaeFAERS: 1US FAERS
849PhonophobiaFAERS: 1US FAERS
850Physical assaultFAERS: 1US FAERS
851PolyhydramniosFAERS: 1US FAERS
852Post-Traumatic Stress DisorderFAERS: 1US FAERS
853Pregnancy test positiveFAERS: 1US FAERS
854Procedural complicationFAERS: 1US FAERS
855Product administered to patient of inappropriate ageFAERS: 1US FAERS
856Product administration errorFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
857Product blister packaging issueFAERS: 1US FAERS
858Product contaminationFAERS: 1US FAERS
859Product contamination microbialFAERS: 1US FAERS
860Product contamination physicalFAERS: 1US FAERS
861Product dosage form issueFAERS: 1US FAERS
862Product label on wrong productFAERS: 1US FAERS
863Product lot number issueFAERS: 1US FAERS
864Product name confusionFAERS: 1US FAERS
865Product quality control issueFAERS: 1US FAERS
866ProteinuriaFAERS: 120685820CTD
US FAERS
867Pulmonary HypertensionFAERS: 1OFFSIDES
US FAERS
868Pulmonary function test decreasedFAERS: 1US FAERS
869Pulmonary painFAERS: 1US FAERS
870Pupillary light reflex tests abnormalFAERS: 1US FAERS
871PyelonephritisFAERS: 1US FAERS
872Radiation associated painFAERS: 1US FAERS
873Reaction to excipientFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
874Reaction to food additiveFAERS: 1US FAERS
875Rectal crampsFAERS: 1US FAERS
876Rectal dischargeFAERS: 1US FAERS
877Reflux gastritisFAERS: 1OFFSIDES
US FAERS
878Respiratory DepressionFAERS: 1US FAERS
879RhabdomyolysisFAERS: 1US FAERS
880RhinitisFAERS: 1SIDER
US FAERS
881RosaceaFAERS: 1US FAERS
882Salivary gland painFAERS: 1US FAERS
883Scarlet FeverFAERS: 1US FAERS
884SchizophreniaFAERS: 1US FAERS
885SciaticaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
886Sexual relationship changeFAERS: 1US FAERS
887Similar reaction on previous exposure to drugFAERS: 1US FAERS
888Simple Partial SeizuresFAERS: 1US FAERS
889Sinus polypFAERS: 1US FAERS
890Sjogren's SyndromeFAERS: 1US FAERS
891Skeletal injuryFAERS: 1US FAERS
892Skin necrosisFAERS: 1US FAERS
893Skin texture abnormalFAERS: 1US FAERS
894Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
895Sperm concentration decreasedFAERS: 1US FAERS
896Sperm count decreasedFAERS: 1US FAERS
897Spermatozoa abnormalFAERS: 1US FAERS
898Stereotypic Movement DisorderFAERS: 17902980CTD
US FAERS
899Stress at workFAERS: 1US FAERS
900StuporFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
901Sudden deathFAERS: 1US FAERS
902SymphysiolysisFAERS: 1US FAERS
903TachyarrhythmiaFAERS: 1US FAERS
904Tattoo excisionFAERS: 1US FAERS
905Temperature regulation disorderFAERS: 1US FAERS
906Tendon discomfortFAERS: 1US FAERS
907Tension HeadacheFAERS: 1US FAERS
908TetanyFAERS: 1US FAERS
909Therapeutic product effect decreasedFAERS: 1US FAERS
910Therapeutic response changedFAERS: 1US FAERS
911ThrombocytopeniaFAERS: 1US FAERS
912TonsillectomyFAERS: 1US FAERS
913TonsillitisFAERS: 1US FAERS
914Toxic Epidermal NecrolysisFAERS: 1US FAERS
915Toxicologic test abnormalFAERS: 1US FAERS
916Tracheal painFAERS: 1US FAERS
917Transmission of an infectious agent via a medicinal productFAERS: 1US FAERS
918Trigeminal Nerve DisorderFAERS: 1US FAERS
919Tryptase increasedFAERS: 1US FAERS
920Tympanic Membrane PerforationFAERS: 1US FAERS
921Ultrasound Doppler abnormalFAERS: 1US FAERS
922Uterine CancerFAERS: 1US FAERS
923Vaginal DischargeFAERS: 1US FAERS
924VasculitisFAERS: 18746358CTD
US FAERS
925VasospasmFAERS: 1US FAERS
926Venous ThrombosisFAERS: 1US FAERS
927Venous occlusionFAERS: 1OFFSIDES
US FAERS
928Viral load increasedFAERS: 1US FAERS
929Vulvovaginal pruritusFAERS: 1US FAERS
930Weight below normalFAERS: 1US FAERS
931Wheelchair userFAERS: 1OFFSIDES
US FAERS
932Wound InfectionFAERS: 1US FAERS
933Wrong doseFAERS: 1US FAERS
934X-ray abnormalFAERS: 1US FAERS
935Abnormal visionOFFSIDES
SIDER
936Abnormalities, Drug-Induced16193507CTD
937Acute respiratory failureOFFSIDES
938AdenocarcinomaOFFSIDES
939Akinetic Mutism19455735CTD
940Allergic pharyngitisOFFSIDES
941AlveolitisOFFSIDES
942Amphetamine-Related Disorders15542755
16820538
19733448
CTD
943Aneurysm, Ruptured12764233CTD
944Anticholinergic SyndromeOFFSIDES
945AnuriaOFFSIDES
946Anxiety Disorders15991002
26688438
CTD
947Aortic Aneurysm9179092
9687945
CTD
948Aortic Diseases15025861
20050989
20694523
CTD
949Apnea

View details

CTD
OFFSIDES
950Arthrogryposis8073369CTD
951AtelectasisOFFSIDES
952Atherosclerosis

View details

CTD
OFFSIDES
953Auditory Perceptual Disorders10578459CTD
954AuraOFFSIDES
955AutomatismOFFSIDES
956Bed restOFFSIDES
957Benign NeoplasmOFFSIDES
958Birth Weight28555334CTD
959Blood GlucoseOFFSIDES
960Blood creatine phosphokinase increasedCanada Vigilance: 2Canada Vigilance
961Body Weight26776438CTD
962Brain Diseases10837795
14980338
22498344
CTD
963Brain Edema20324
19782326
CTD
964Brain Injuries18803299CTD
965Brain stem syndromeOFFSIDES
966Bronchial ObstructionOFFSIDES
967Bronchopulmonary DysplasiaOFFSIDES
968BunionOFFSIDES
969Calcinosis16378124CTD
970Carcinoma, Transitional Cell29501575CTD
971Cardiomyopathies19559087CTD
972Cardiovascular Diseases

View details

CTD
973Carotid bruitOFFSIDES
974Cartilage Diseases29660438CTD
975Cartilage injuryOFFSIDES
976Catalepsy

View details

CTD
977Cerebral Hemorrhage7658896
8073369
CTD
978Cerebrovascular Disorders8100951CTD
979Cervical Intraepithelial Neoplasia20190800CTD
980Chemical and Drug Induced Liver Injury8884888CTD
981Chest tightnessSIDER
982Chest wall painOFFSIDES
983Chronic Obstructive Airway DiseaseOFFSIDES
984Chronic ulcerative colitisOFFSIDES
985ClaustrophobiaCanada Vigilance: 1Canada Vigilance
986Cocaine-Related Disorders9543646
12110995
14975690
CTD
987Cognition Disorders

View details

CTD
988Colitis23810507CTD
OFFSIDES
989Colonic Neoplasms14569062
17369603
CTD
990Conduct Disorder19628140CTD
991Congenital teratomaOFFSIDES
992Conjunctival depositOFFSIDES
993ConjunctivitisCanada Vigilance: 2Canada Vigilance
994Contact DermatitisOFFSIDES
995Coxsackievirus Infections25396421CTD
996Cramps of lower extremitiesSIDER
997Deep Vein ThrombosisCanada Vigilance: 1Canada Vigilance
998Depressive disorder

View details

CTD
999Diarrhea2371153CTD
OFFSIDES
1000Dissociative disorderCanada Vigilance: 1Canada Vigilance
1001DiverticulosisOFFSIDES
1002Dreaming excessiveSIDER
1003Dyskinesia, Drug-Induced

View details

CTD
1004Edema12575837CTD
1005Endoscopy abnormalOFFSIDES
1006Endotoxemia19265175CTD
1007Eosinophilia12575837CTD
1008Erythema NodosumCanada Vigilance: 1Canada Vigilance
1009Escherichia infectionOFFSIDES
1010Esophageal PerforationOFFSIDES
1011Exanthema8028537
10392670
CTD
1012Eye inflammationOFFSIDES
1013Facial paralysisCanada Vigilance: 1Canada Vigilance
1014Fatty Liver8884888
25662863
26776438
CTD
1015Fear of fallingOFFSIDES
1016Febrile NeutropeniaOFFSIDES
1017Feeding and Eating Disorders9746444CTD
1018Fetal Growth Retardation

View details

CTD
1019Fever8746358
15138183
CTD
1020Fibroadenoma of breastCanada Vigilance: 1Canada Vigilance
1021Flank PainCanada Vigilance: 2Canada Vigilance
1022Flat affectSIDER
1023Full blood count decreasedOFFSIDES
1024Gastrointestinal discomfortSIDER
1025Glomerulonephritis20685820CTD
1026Glucose Metabolism Disorders18852877CTD
1027GoiterOFFSIDES
1028Head and Neck Neoplasms11592233CTD
1029HeartburnSIDER
1030Heparin-induced thrombocytopeniaOFFSIDES
1031Herpes LabialisSIDER
1032HiccoughOFFSIDES
1033Hip DysplasiaOFFSIDES
1034HoarsenessSIDER
1035Hormone level abnormalCanada Vigilance: 1Canada Vigilance
OFFSIDES
1036Hyperalgesia16915382CTD
1037Hyperemia15500638CTD
1038Hyperglycemia29155039CTD
1039HyperkinesiaCanada Vigilance: 1Canada Vigilance
1040Hyperplasia24269753
29501575
CTD
1041Hypertriglyceridemia24368177CTD
1042Immune System Diseases30605750CTD
1043Influenza-like symptomsSIDER
1044Injection Site ReactionCanada Vigilance: 1Canada Vigilance
1045Insulin Resistance17906372
29155039
CTD
1046Intention tremorOFFSIDES
1047Intervertebral Disc Degeneration11484105CTD
1048Intracranial Embolism and Thrombosis245329CTD
1049Intraocular inflammationOFFSIDES
1050Ischemia19559087
21511693
CTD
1051Kidney FailureOFFSIDES
1052Language Development Disorders8001318CTD
1053Language Disorders23691092CTD
1054Liver diseases15925865CTD
1055Local reactionSIDER
1056Long QT Syndrome12766260CTD
1057Lung Diseases, Interstitial22691361CTD
1058Lung Neoplasms

View details

CTD
1059Lung diseases15925865
17868207
21378373
CTD
1060LymphedemaOFFSIDES
1061MPTP Poisoning9503263
19594327
20230807
CTD
1062Malignant neoplasm progressionOFFSIDES
1063Memory Disorders8968367CTD
1064MetastasisCanada Vigilance: 1Canada Vigilance
1065Metastatic Renal Cell CarcinomaOFFSIDES
1066Mitochondrial Diseases20960268CTD
1067Movement Disorders18803299
28082123
CTD
1068Multiple sclerosis relapseCanada Vigilance: 2Canada Vigilance
1069Muscle SpasticityCanada Vigilance: 1Canada Vigilance
1070Muscular Atrophy18694773CTD
1071Myasthenic SyndromeCanada Vigilance: 1Canada Vigilance
1072Myocardial Reperfusion Injury8124816CTD
1073Myocarditis25396421CTD
1074Neonatal aspirationOFFSIDES
1075Neoplasm Invasiveness

View details

CTD
1076Neoplasm Metastasis20061081CTD
1077Neoplasms, Experimental20457658CTD
1078Neoplasms

View details

CTD
1079Nerve Degeneration11430869
11578609
CTD
1080Neural Tube Defects16193507CTD
1081Neurobehavioral Manifestations20363831CTD
1082Neurogenic BowelOFFSIDES
1083Neurotoxicity Syndromes15039772CTD
1084Nociceptive Pain11708903CTD
1085Nose Neoplasms20338106CTD
1086NumbnessSIDER
1087Obsessive-Compulsive Disorder26688438CTD
1088Oligospermia20498001CTD
1089Pancreatic Diseases18852877CTD
1090Pedal pulse decreasedOFFSIDES
1091Periodontal Diseases12200972CTD
1092Peripheral Nervous System Diseases16915382CTD
1093Peripheral Vascular Diseases19559087CTD
1094Polycythemia2615289CTD
1095PolyuriaCanada Vigilance: 1Canada Vigilance
1096Post procedural infectionOFFSIDES
1097Postoperative Complications8522735CTD
1098Prenatal Exposure Delayed Effects

View details

CTD
1099Prenatal Injuries24709674
29981921
CTD
1100Pressure Ulcer19673871CTD
1101ProctitisOFFSIDES
1102Propofol Infusion SyndromeOFFSIDES
1103Psychoses, Substance-Induced11331147CTD
1104Psychotic Disorders17383738CTD
1105Pulmonary Edema19782326CTD
1106Pulmonary Fibrosis22691361CTD
1107Pulmonary thrombosisOFFSIDES
1108Purpura8746358CTD
1109Rectal ProlapseOFFSIDES
1110RednessSIDER
1111Reflex, Abnormal1736170CTD
1112Reperfusion Injury19673871
21511693
CTD
1113Respiration Disorders9565740
20617012
CTD
1114Respiratory Insufficiency1179485CTD
1115Respiratory ParalysisSIDER
1116Respiratory Sounds27806211CTD
1117Respiratory Tract Diseases27806211CTD
1118Retinal Diseases20448088CTD
1119Rheumatoid ArthritisCanada Vigilance: 1Canada Vigilance
1120RhinorrheaOFFSIDES
1121Risus sardonicusOFFSIDES
1122Seizures

View details

CTD
1123Septic ShockOFFSIDES
1124Serum SicknessCanada Vigilance: 1Canada Vigilance
1125Sialorrhea9746444CTD
1126Sinoatrial Block1259687CTD
1127Skin IndurationOFFSIDES
1128Skin Neoplasms15029439CTD
1129Sleep Initiation and Maintenance Disorders9746444
20182857
CTD
1130Sleep Wake Disorders

View details

CTD
1131Spasm539451
1259687
CTD
1132Spina Bifida Cystica22473653CTD
1133Stomach Neoplasms17003101
18805435
20061081
CTD
1134Subarachnoid Hemorrhage12764233CTD
1135Substance Withdrawal Syndrome

View details

CTD
1136Substance-Related Disorders12434259
16554741
21113126
CTD
1137SuicideSIDER
1138SyringomyeliaOFFSIDES
1139Therapeutic product effect increasedCanada Vigilance: 1Canada Vigilance
1140Thromboangiitis Obliterans12474585CTD
1141Tobacco Use Disorder

View details

CTD
1142Tracheal Diseases12575837CTD
1143Ulcerative stomatitisSIDER
1144Urinary Bladder Diseases15025861CTD
1145Uterine PolypOFFSIDES
1146Vascular Diseases

View details

CTD
1147Vasculitis, Leukocytoclastic, Cutaneous8746358CTD
1148Venous thrombosis limbOFFSIDES
1149Ventricular FibrillationOFFSIDES
1150Vulvovaginal burning sensationOFFSIDES
1151Weight Gain8956374
29155039
CTD
1152effusionOFFSIDES
1153melanoma15029439CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.